There are other forms of bias in these datasets including channeling (e.g., the prescribing pattern depends on a patient characteristic (particularly diabetes or obesity) that is a PDAC risk factor), detection (e.g., overreporting due to additional testing to rule out a suspected adverse event (e.g., imaging triggered by pancreas enzyme elevations)), and Weber effect (initial increase in event reporting shortly after drug launch) 49
A doctor may adjust the medication dose, slow the titration schedule, review food timing, change constipation support, check labs, assess hydration, evaluate other medications, or pause treatment when needed
Medicamentos que imitam seu efeito potencializam esses mecanismos, permitindo reduo de gordura corporal de forma mais consistente, mesmo sem dietas extremamente restritivas
The options may be chosen on the product page FAQs What are the most common GLP-1 side effects